Literature DB >> 2633047

N-deglycosylation of human complement component C9 reduces its hemolytic activity.

R Kontermann1, E W Rauterberg.   

Abstract

The effect of enzymatic deglycosylation of human complement component C9 on its hemolytic activity was investigated. Treatment of native C9 (Mr 71,000) with glyocpeptidase F (PNGase F) results in a stepwise decrease of the mol. wt. The formation of an Mr 67,000 peptide which is further converted to Mr 63,000 suggests that there are two N-linked carbohydrate chains per C9 polypeptide. Removal of approximately 88% of the N-linked oligosaccharides results in 80% reduction of the hemolytic activity (CH50). The completely N-deglycosylated Mr 63,000 peptide contains a remaining amount of 25% of the total carbohydrates of native C9. These glycans are assumed to be O-linked and predominantly attached to the C9a part of C9. The electrophoretic mobility of C9 is not affected by endoglycosidase F or H treatments revealing that the two N-linked glycans are of the tri- or tetra-antennary complex type. Cleavage of terminal sialic acids from native C9 by neuraminidase results in an Mr 67,000 product with nearly unaltered hemolytic activity. In contrast to other glycoproteins in which deglycosylation remained without major effects on their functional activity, our findings suggest that the N-linked carbohydrates are required for full expression of hemolytic activity of C9.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2633047     DOI: 10.1016/0161-5890(89)90056-4

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

1.  Topology of the membrane-bound form of complement protein C9 probed by glycosylation mapping, anti-peptide antibody binding, and disulfide modification.

Authors:  Véronique Rossi; Yunxia Wang; Alfred F Esser
Journal:  Mol Immunol       Date:  2010-02-12       Impact factor: 4.407

2.  α2,6-Sialylation is Upregulated in Severe COVID-19 Implicating the Complement Cascade.

Authors:  Rui Qin; Emma Kurz; Shuhui Chen; Briana Zeck; Luis Chiribogas; Dana Jackson; Alex Herchen; Tyson Attia; Michael Carlock; Amy Rapkiewicz; Dafna Bar-Sagi; Bruce Ritchie; Ted M Ross; Lara K Mahal
Journal:  medRxiv       Date:  2022-06-08

3.  Altered glycosylation and selected mutation in recombinant human complement component C9: effects on haemolytic activity.

Authors:  K M Taylor; B P Morgan; A K Campbell
Journal:  Immunology       Date:  1994-11       Impact factor: 7.397

4.  Proteoform Profile Mapping of the Human Serum Complement Component C9 Revealing Unexpected New Features of N-, O-, and C-Glycosylation.

Authors:  Vojtech Franc; Yang Yang; Albert J R Heck
Journal:  Anal Chem       Date:  2017-03-07       Impact factor: 6.986

5.  α2,6-Sialylation Is Upregulated in Severe COVID-19, Implicating the Complement Cascade.

Authors:  Rui Qin; Emma Kurz; Shuhui Chen; Briana Zeck; Luis Chiribogas; Dana Jackson; Alex Herchen; Tyson Attia; Michael Carlock; Amy Rapkiewicz; Dafna Bar-Sagi; Bruce Ritchie; Ted M Ross; Lara K Mahal
Journal:  ACS Infect Dis       Date:  2022-10-11       Impact factor: 5.578

Review 6.  Breaching the Bacterial Envelope: The Pivotal Role of Perforin-2 (MPEG1) Within Phagocytes.

Authors:  Leidy C Merselis; Zachary P Rivas; George P Munson
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.